Shares of BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) were up 0.6% during trading on Monday . The company traded as high as $11.4240 and last traded at $11.4240. Approximately 439 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 2,433 shares. The stock had previously closed at $11.3599.
BioSyent Stock Up 0.6%
The firm’s fifty day moving average is $10.33 and its two-hundred day moving average is $9.08.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
See Also
- Five stocks we like better than BioSyent
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
